Axcella Health Inc.
NASDAQ: AXLA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig R. Jalbert CIRA
- Employees
- 11
- Headquarters
- Cambridge, United States
- IPO year
- 2019
- Market cap
- $12.5M
- Website
- https://www.axcellahealth.com
Loading AXLA…
Loading profile data…Frequently asked questions about AXLA
What does Axcella Health Inc. (AXLA) do?
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical...
Where does AXLA trade?
Axcella Health Inc. (AXLA) trades on the NASDAQ Global Market.
What sector is AXLA in?
Axcella Health Inc. (AXLA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Axcella Health Inc.?
Craig R. Jalbert CIRA is the chief executive officer of Axcella Health Inc. (AXLA).
Where is Axcella Health Inc. headquartered?
Axcella Health Inc. is headquartered in United States.
Does AXLA pay a dividend?
Axcella Health Inc. (AXLA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXLA go public?
Axcella Health Inc. (AXLA) completed its initial public offering in 2019.